<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01407627</url>
  </required_header>
  <id_info>
    <org_study_id>UCalgary Sugar Study</org_study_id>
    <secondary_id>AIHS</secondary_id>
    <secondary_id>University of Calgary</secondary_id>
    <nct_id>NCT01407627</nct_id>
  </id_info>
  <brief_title>Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans</brief_title>
  <official_title>Evaluation of Fructose Ingestion and the Renin Angiotensin System in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fructose is an ingredient that is added to many of our foods. It is a cheaper, sweeter&#xD;
      additive that can be found in everything from soda pop to yogurt to granola bars. In the last&#xD;
      few years a significant number of studies have been published linking consumption of fructose&#xD;
      with obesity, hypertension and more recently, kidney and cardiovascular disease.&#xD;
&#xD;
      Animal studies show a strong link between excessive ingestion of fructose and the development&#xD;
      of kidney and cardiovascular disease mediated by the renin angiotensin system, a hormonal&#xD;
      system whose activation is detrimental to both the kidney and the heart. There has been very&#xD;
      little research done on the potentially pathophysiological relationship between a high&#xD;
      fructose diet and kidney and cardiovascular disease in humans.&#xD;
&#xD;
      The investigators hypothesize that ingestion of fructose will result in upregulation of the&#xD;
      renin angiotensin system in humans.&#xD;
&#xD;
      Cardiovascular disease in women is a significant risk factor. By having women participate who&#xD;
      are on the birth control pill and as well as women who use non oral forms of birth control or&#xD;
      no birth control, kidney function and cardiovascular health can be examined as it relates to&#xD;
      in the influence oral hormones might play. How the kidney responds to the influence of sugar&#xD;
      and fructose while a woman is on an oral birth control pill, may reveal mechanisms that could&#xD;
      help us understand cardiovascular disease in women.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY AIM: To examine whether the physiologic and molecular responses to Angiotensin II&#xD;
      (AngII) challenge differ in response to fructose intake as assessed by two independent means:&#xD;
&#xD;
        1. The renal and mean arterial pressure (MAP) response to an AngII challenge.&#xD;
&#xD;
        2. Reactive changes in circulating levels of renin and aldosterone with graded AngII&#xD;
           challenge.&#xD;
&#xD;
      PRIMARY HYPOTHESES: Ingestion of fructose in healthy subjects will result in:&#xD;
&#xD;
        1. A decrease in renal and systemic sensitivity to infused AngII.&#xD;
&#xD;
        2. A decrease in the reactive changes in renin and aldosterone with graded AngII challenge.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in filtration fraction</measure>
    <time_frame>after 2 weeks of ingestion of fructose compared to baseline value</time_frame>
    <description>To examine whether the physiologic and molecular responses to an Angiotensin II challenge differ in response to fructose intake as assessed by reactive changes in circulating levels of renin and aldosterone with a graded Angiotensin II challenge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in blood pressure in response to angiotensin II challenge</measure>
    <time_frame>change after 2 weeks of fructose ingestion</time_frame>
    <description>To examine whether the physiologic and molecular responses to an Angiotensin II challenge differ in response to fructose intake as assessed by renal and mean arterial pressure (MAP) response to an Angiotensin II challenge.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Fructose First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study Day 1 - measurement of renal hemodynamics and blood pressure&#xD;
Subjects will ingest fructose 200g daily x 14d&#xD;
Study Day 2 - measurement of renal hemodynamics&#xD;
Minimum 1 week &quot;washout&quot; period&#xD;
Subjects will ingest dextrose 200g daily x 14d&#xD;
Study Day 3 - measurement of renal hemodynamics and blood pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose First</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study Day 1 - measurement of renal hemodynamics and blood pressure&#xD;
Subjects will ingest dextrose 200g daily x 14d&#xD;
Study Day 2 - measurement of renal hemodynamics&#xD;
Minimum 1 week &quot;washout&quot; period&#xD;
Subjects will ingest fructose 200g daily x 14d&#xD;
Study Day 3 - measurement of renal hemodynamics and blood pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose</intervention_name>
    <description>Subjects will be randomized to one of 2 sequences:&#xD;
Sequence 1: Fructose (intervention) 200g daily x 14d followed by Dextrose (control) 200g daily x 14d Sequence 2: Dextrose (control) 200g daily x 14d followed by Fructose (intervention) 200g daily x 14d</description>
    <arm_group_label>Dextrose First</arm_group_label>
    <arm_group_label>Fructose First</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ageâ‰¥18 years,&#xD;
&#xD;
          -  able to comprehend study and comply with high-salt diet&#xD;
&#xD;
          -  kidney disease (on the approval of their nephrologist)&#xD;
&#xD;
          -  on an oral birth control pill and non oral birth control and those not on birth&#xD;
             control&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiovascular disease (symptoms consistent with myocardial ischemia, previously&#xD;
             documented myocardial ischemia, cardiac arrhythmias or valve abnormalities, or&#xD;
             abnormal ECG at screening)&#xD;
&#xD;
          -  cerebrovascular disease (transient ischemic attacks or stroke)&#xD;
&#xD;
          -  hypertension (BP&gt;140/90 or use of antihypertensive medications)&#xD;
&#xD;
          -  diabetes mellitus (defined by history, use of hypoglycemic agents or a fasting glucose&#xD;
             &gt;7mmol/L)&#xD;
&#xD;
          -  hyperlipidemia (LDL &gt;4.5mmol/L or use of lipid-lowering agents)&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sofia B Ahmed, MD MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darlene Sola, RN, BScN</last_name>
      <phone>(403) 944-2745</phone>
      <email>dsola@ucalgary.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 29, 2011</study_first_submitted>
  <study_first_submitted_qc>August 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2011</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Sofia Ahmed</investigator_full_name>
    <investigator_title>Dr. Sofia Ahmed</investigator_title>
  </responsible_party>
  <keyword>human</keyword>
  <keyword>fructose</keyword>
  <keyword>dextrose</keyword>
  <keyword>renin angiotensin system</keyword>
  <keyword>kidney</keyword>
  <keyword>renal hemodynamics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

